Waldencast plc (WALD)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Waldencast: Learning To Grow Hurts Sometimes
Waldencast is a fast-growing beauty company with strong brands (Milk Makeup, Obagi), but faces margin pressure and negative earnings due to high SG&A and debt. Recent revenue growth remains solid, but Q1 FY25 saw a sales dip, especially in Milk Makeup, due to international headwinds and inventory adjustments. The company's financials are typical for a high-growth firm: negative cash flow, high leverage, but manageable liquidity, and a long debt runway until 2030.
Waldencast plc (WALD) Q1 2025 Earnings Call Transcript
Waldencast plc (NASDAQ:WALD ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Allison Malkin - Partner ICR, Investor Relations Michel Brousset - Founder & Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants John Chapman - Alliance Global Partners Jonna Kim - TD Cowen Operator Good day, and welcome to the Waldencast First Quarter 2025 Earnings Call. All participants will be in listen-only mode.
Waldencast plc (WALD) Q4 2024 Earnings Call Transcript
Waldencast plc (NASDAQ:WALD ) Q4 2024 Earnings Conference Call March 19, 2025 8:30 AM ET Company Participants Allison Malkin - Investor Relations Michel Brousset - Founder and Chief Executive Officer Manuel Manfredi - Chief Financial Officer Conference Call Participants Jonna Kim - TD Cowen Ashley Helgans - Jefferies Linda Bolton Weiser - D.A. Davidson Olivia Tong - Raymond James Operator Greetings, welcome to the Waldencast Fourth Quarter and Fiscal Year 2024 Earnings Call.
Waldencast plc (WALD) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Waldencast plc ever had a stock split?
Waldencast plc Profile
| Software Industry | Information Technology Sector | Michel Brousset CEO | NASDAQ (CM) Exchange | G9503X103 CUSIP |
| US Country | 335 Employees | - Last Dividend | 28 Jul 2022 Last Split | 11 May 2021 IPO Date |
Overview
Waldencast Acquisition Corp. is a prominent entity in the skincare industry, primarily known for its innovative approach to advanced skincare treatments. Established in 1988 and based in White Plains, New York, the company has carved a niche for itself by focusing on products that combat the signs of premature skin aging, damage due to sun exposure, hyperpigmentation, acne, and other skin concerns. These products are widely available and endorsed by dermatologists, plastic surgeons, medical spas, and skincare professionals, ensuring they reach those in need of professional-grade skincare solutions.
Products and Services
Waldencast Acquisition Corp. boasts a diverse portfolio through its key brands, Obagi Medical and Obagi Clinical, each designed to cater to specific skin health needs:
- Obagi Medical: This line is renowned for its transformational skincare products that are specifically formulated to tackle the visible signs of skin aging. Products under Obagi Medical target dark spots, hyperpigmentation, fine lines, and wrinkles, effectively helping to rejuvenate and maintain skin health. In addition to anti-aging properties, these products also focus on enhancing skin tone and texture, offering comprehensive skincare solutions to those looking to maintain youthful, vibrant skin.
- Obagi Clinical: Tailored for individuals aiming to prevent the early signs of skin aging, Obagi Clinical offers an array of skincare products. These items are meticulously designed to safeguard the skin from potential damage while nurturing it to prevent the onset of wrinkles, fine lines, and other premature aging indicators. Much like its counterpart, Obagi Clinical emphasizes maintaining and enhancing the skin's tone and texture, equipping users with the tools they need for proactive skin care.
Contact Information
